Brevan Howard Capital Management’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$889K Buy
9,842
+3,961
+67% +$336K 0.01% 1131
2026
Q1
$491K Buy
5,881
+1,124
+24% +$92.2K ﹤0.01% 1310
2025
Q4
$436K Sell
4,757
-11,557
-71% -$1.11M ﹤0.01% 1178
2025
Q3
$1.55M Sell
16,314
-11,141
-41% -$1.05M 0.01% 685
2025
Q2
$2.88M Buy
27,455
+19,050
+227% +$1.81M 0.02% 593
2025
Q1
$743K Buy
8,405
+6,316
+302% +$648K 0.01% 600
2024
Q4
$200K Buy
+2,089
New +$195K ﹤0.01% 914

Other funds holding HQY

Brevan Howard Capital Management's HQY Position: Q2 2026 in Review

Brevan Howard Capital Management increased its HealthEquity (HQY) stake by 67% in Q2 2026, buying an estimated $336K and bringing the position to 9,842 shares worth $889K. The position accounts for 0.01% of the portfolio, ranked #1131.

Brevan Howard Capital Management first reported a position in HQY in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.88M in Q2 2025. 501 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Brevan Howard Capital Management held 9,842 shares of HealthEquity worth $889K as of Q2 2026.
  • Brevan Howard Capital Management bought 3,961 HealthEquity shares in Q2 2026, an estimated $336K.
  • HealthEquity made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1131 holding.
  • Brevan Howard Capital Management first reported a position in HealthEquity in Q4 2024 and has held it in 7 quarters since.
  • Brevan Howard Capital Management's HealthEquity position peaked at $2.88M in Q2 2025.
  • 501 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.